세계의 신속 의료 진단 키트 시장 - 규모, 점유율, 성장 분석 : 제품별, 기술별, 용도별, 최종 용도별, 지역별 산업 예측(2025-2032년)
Rapid Medical Diagnostic Kits Market Size, Share, Growth Analysis, By Product (Over the Counter (OTC) Kits, Professional Kits), By Technology (Lateral Flow, Agglutination), By Application, By End Use, By Region - Industry Forecast 2025-2032
상품코드:1622366
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
신속 의료 진단 키트 시장 규모는 2023년에 166억 7,000만 달러로 평가되며 예측 기간(2025-2032년)의 CAGR은 3.4%로, 2024년 172억 4,000만 달러에서 2032년에는 225억 3,000만 달러로 나타날 전망입니다.
신속 의료 진단 키트 시장은 COVID-19와 인플루엔자와 같은 감염 유행 증가에 견인되어 강력한 성장을 이루고 있습니다. 이러한 키트 수요를 현저하게 높여 아웃브레이크의 보다 나은 관리를 촉진하고 있습니다. 다양한 건강 관리 환경에서의 채용을 촉진하고 있습니다. 그러나 시장은 규제상의 장애물과 신뢰할 수있는 결과를 보장하고 오진으로 인한 잠재적 건강 위험을 방지하기 위한 엄격한 품질 관리 필수 요성과 같은 과제에 직면하고 있습니다. 경쟁의 격화는 연구 개발에의 지속적인 투자를 필요로 하고, 각사는 시장 우위성을 유지해, 진화하는 의료 수요에 대응하기 위한 기술 혁신을 강요하고 있습니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
무역 분석
고객 및 구매 기준 분석
신속 의료 진단 키트 시장 규모 : 제품별
시장 개요
시판(OTC) 키트
프로페셔널 키트
신속 의료 진단 키트 시장 규모 : 기술별
시장 개요
래터럴 플로우
응집
고상
기타 기술
신속 의료 진단 키트 시장 규모 : 용도별
시장 개요
혈당 검사
감염증 검사
COVID-19
간염
HIV
인플루엔자
기타
심장 대사 검사
임신과 불임 검사
변잠혈검사
응고 검사
독성시험
지질 프로파일 검사
기타 용도
신속 의료 진단 키트 시장 규모 : 최종 용도별
시장 개요
병원 및 클리닉
홈케어
진단 실험실
기타
신속 의료 진단 키트 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년 대비 비교(2022-2024)
주요 기업 프로파일
Abbott Laboratories(USA)
ACON Laboratories Inc.(USA)
Alfa Scientific Designs Inc.(USA)
Artron Laboratories Inc.(Canada)
F. Hoffmann-La Roche Ltd.(Switzerland)
Becton, Dickinson and Company(USA)
bioMerieux SA(France)
BTNX Inc.(Canada)
Creative Diagnostics(USA)
Danaher Corporation(USA)
Siemens Healthcare GmbH(Germany)
Bio-Rad Laboratories Inc.(USA)
Cardinal Health(USA)
Meridian Bioscience Inc.(USA)
Zoetis Inc.(USA)
McKesson Medical-Surgical Inc.(USA)
Trinity Biotech(Ireland)
Hologic Inc.(USA)
Atlas Link Biotech Co. Ltd.(China)
SD Biosensor Inc.(South Korea)
결론과 권장사항
JHS
영문 목차
영문목차
Rapid Medical Diagnostic Kits Market size was valued at USD 16.67 Billion in 2023 and is poised to grow from USD 17.24 Billion in 2024 to USD 22.53 Billion by 2032, growing at a CAGR of 3.4% during the forecast period (2025-2032).
The rapid medical diagnostic kits market is experiencing robust growth, driven by the rising prevalence of infectious diseases like COVID-19 and influenza. The pandemic significantly heightened the demand for these kits, essential for mass testing and early disease detection, thus facilitating better management of outbreaks. Technological innovations have further improved the accuracy, sensitivity, and user-friendliness of these diagnostic tools, promoting adoption in various healthcare settings, including resource-limited environments. However, the market faces challenges such as regulatory hurdles and the need for stringent quality control to ensure reliable results, preventing potential health risks from false diagnoses. Intensifying competition necessitates continuous investment in research and development, compelling companies to innovate to maintain their market edge and meet evolving healthcare demands.
Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Medical Diagnostic Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Rapid Medical Diagnostic Kits Market Segmental Analysis
Global Rapid Medical Diagnostic Kits Market is segmented by product, technology, application, end use and region. Based on product, the market is segmented into over the counter (OTC) kits and professional kits. Based on technology, the market is segmented into lateral flow, agglutination, solid phase and other technologies. Based on application, the market is segmented into blood glucose testing, infectious disease testing, cardiometabolic testing, pregnancy & fertility testing, fecal occult blood testing, coagulation testing, toxicology testing, lipid profile testing and other applications. Based on end use, the market is segmented into hospitals & clinics, home care, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Rapid Medical Diagnostic Kits Market
The demand for rapid medical diagnostic kits is being significantly driven by the escalating prevalence of infectious diseases, including COVID-19, influenza, HIV, and various sexually transmitted infections. As the incidence of these illnesses rises, the need for swift and precise diagnostic solutions becomes increasingly critical. Rapid medical diagnostic kits play a vital role in enabling timely detection of pathogens, which is essential for effective disease management and control. This trend is further amplified by the growing emphasis on early diagnosis to improve patient outcomes, thus propelling the market forward as healthcare providers seek reliable tools for prompt decision-making in infectious disease management.
Restraints in the Rapid Medical Diagnostic Kits Market
The Rapid Medical Diagnostic Kits market encounters significant restraints primarily due to stringent regulatory requirements. These kits are subject to rigorous standards that ensure their safety, accuracy, and reliability, necessitating comprehensive regulatory approvals. This process can be both time-consuming and costly, which may hinder market entry, particularly for smaller manufacturers that lack the resources to navigate the complexities of compliance. As a result, the demanding nature of these regulations can limit innovation and competition within the industry, ultimately affecting the availability and diversity of rapid diagnostic solutions in the market.
Market Trends of the Rapid Medical Diagnostic Kits Market
The Rapid Medical Diagnostic Kits market is witnessing a significant trend towards the development of portable and user-friendly devices. This shift is driven by the increasing demand for point-of-care testing, which is essential in resource-limited settings and remote areas where access to traditional laboratory facilities is challenging. Manufacturers are focusing on innovative designs that feature intuitive interfaces and simplified instructions, making these diagnostic tools more accessible for both healthcare professionals and consumers. As a result, this trend not only enhances the efficacy of disease detection and management but also promotes greater engagement in health monitoring, catering to an expanding global customer base.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis
Customer & Buying Criteria Analysis
Global Rapid Medical Diagnostic Kits Market Size by Product & CAGR (2025-2032)
Market Overview
Over The Counter (OTC) Kits
Professional Kits
Global Rapid Medical Diagnostic Kits Market Size by Technology & CAGR (2025-2032)
Market Overview
Lateral Flow
Agglutination
Solid Phase
Other Technologies
Global Rapid Medical Diagnostic Kits Market Size by Application & CAGR (2025-2032)
Market Overview
Blood Glucose Testing
Infectious Disease Testing
Covid-19
Hepatitis
HIV
Influenza
Others
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Lipid Profile Testing
Other Applications
Global Rapid Medical Diagnostic Kits Market Size by End Use & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Home Care
Diagnostic Laboratories
Others
Global Rapid Medical Diagnostic Kits Market Size & CAGR (2025-2032)
North America (Product, Technology, Application, End Use)
US
Canada
Europe (Product, Technology, Application, End Use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Technology, Application, End Use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Technology, Application, End Use)
Brazil
Rest of Latin America
Middle East & Africa (Product, Technology, Application, End Use)